Upregulated Signaling Pathways in Ruptured Human Saccular Intracranial Aneurysm Wall: An Emerging Regulative Role of Toll-Like Receptor Signaling and Nuclear Factor-κB, Hypoxia-Inducible Factor-1A, and ETS Transcription Factors

BACKGROUND:Aneurysmal subarachnoid hemorrhage, almost always from saccular intracranial aneurysm (sIA), is a devastating form of stroke that affects the working-age population. Cellular and molecular mechanisms predisposing to the rupture of the sIA wall are largely unknown. This knowledge would facilitate the design of novel diagnostic tools and therapies for the sIA disease. OBJECTIVE:To investigate gene expression patterns distinguishing ruptured and unruptured sIA. METHODS:We compared the whole-genome expression profile of 11 ruptured sIA wall samples with that of 8 unruptured ones using oligonucleotide microarrays. Signaling pathways enriched in the ruptured sIA walls were identified with bioinformatic analyses. Their transcriptional control was predicted in silico by seeking the enrichment of conserved transcription factor binding sites in the promoter regions of differentially expressed genes. RESULTS:Overall, 686 genes were significantly upregulated and 740 were downregulated in the ruptured sIA walls. Significantly upregulated biological processes included response to turbulent blood flow, chemotaxis, leukocyte migration, oxidative stress, vascular remodeling; and extracellular matrix degradation. Toll-like receptor signaling and nuclear factor-κB, hypoxia-inducible factor-1A, and ETS transcription factor binding sites were significantly enriched among the upregulated genes. CONCLUSION:We identified pathways and candidate genes associated with the rupture of human sIA wall. Our results may provide clues to the molecular mechanism in sIA wall rupture and insight for novel therapeutic strategies to prevent rupture.

[1]  M. Taneda,et al.  Structural fragility and inflammatory response of ruptured cerebral aneurysms. A comparative study between ruptured and unruptured cerebral aneurysms. , 1999, Stroke.

[2]  M. Baumann,et al.  Involvement of Mitogen-Activated Protein Kinase Signaling in Growth and Rupture of Human Intracranial Aneurysms , 2008, Stroke.

[3]  K. Jain.  Familial intracranial aneurysms , 2005, Acta Neurochirurgica.

[4]  Gordon K Smyth,et al.  Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .

[5]  G. Ailawadi,et al.  Neutrophil Depletion Inhibits Experimental Abdominal Aortic Aneurysm Formation , 2005, Circulation.

[6]  G. Fassina,et al.  Fc gamma RIIIb allele-sensitive release of alpha-defensins: anti-neutrophil cytoplasmic antibody-induced release of chemotaxins. , 2003, Journal of immunology.

[7]  Benjamin M. Bolstad,et al.  affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..

[8]  Craig S. Anderson,et al.  Risk Factors for Subarachnoid Hemorrhage: An Updated Systematic Review of Epidemiological Studies , 2005, Stroke.

[9]  K. Vranizan,et al.  Gene expression patterns define key transcriptional events in cell-cycle regulation by cAMP and protein kinase A. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Alejandro F. Frangi,et al.  Genome-wide association study of intracranial aneurysm identifies three new risk loci , 2010, Nature genetics.

[11]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[12]  Marko Kangasniemi,et al.  Growth Factor Receptor Expression and Remodeling of Saccular Cerebral Artery Aneurysm Walls: Implications for Biological Therapy Preventing Rupture , 2006, Neurosurgery.

[13]  J. Bux,et al.  Human neutrophil alloantigens , 2008, Vox sanguinis.

[14]  L. O’Neill,et al.  Toll‐like receptors: key activators of leucocytes and regulator of haematopoiesis , 2007, British journal of haematology.

[15]  H. Anders,et al.  Chemokine receptors Ccr1, Ccr2, and Ccr5 mediate neutrophil migration to postischemic tissue , 2006, Journal of leukocyte biology.

[16]  H. Jo,et al.  Laminar shear stress inhibits cathepsin L activity in endothelial cells (EC) , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[17]  V. Feigin,et al.  Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review , 2009, The Lancet Neurology.

[18]  K. Takakura,et al.  Network-based gene expression analysis of intracranial aneurysm tissue reveals role of antigen presenting cells , 2008, Neuroscience.

[19]  A. Paetau,et al.  Complement activation associates with saccular cerebral artery aneurysm wall degeneration and rupture. , 2006, Neurosurgery.

[20]  R. Morishita,et al.  NF-&kgr;B Is a Key Mediator of Cerebral Aneurysm Formation , 2007 .

[21]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[22]  P. Oettgen.  Regulation of vascular inflammation and remodeling by ETS factors. , 2006, Circulation research.

[23]  R. Morishita,et al.  NF-kappaB is a key mediator of cerebral aneurysm formation. , 2007, Circulation.

[24]  D. Harrison,et al.  Coronary Artery Superoxide Production and Nox Isoform Expression in Human Coronary Artery Disease , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[25]  G. Ertl,et al.  Mechanisms of Disease: Toll-like receptors in cardiovascular disease , 2007, Nature Clinical Practice Cardiovascular Medicine.

[26]  R. Morishita,et al.  Pharmacological treatment of abdominal aortic aneurysm. , 2009, Cardiovascular research.

[27]  J. Raffetto,et al.  Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. , 2008, Biochemical pharmacology.

[28]  C. Rommel,et al.  PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond? , 2007, Nature reviews. Immunology.

[29]  G. Maira,et al.  Comparative evaluation of genome-wide gene expression profiles in ruptured and unruptured human intracranial aneurysms. , 2010, Journal of biological regulators and homeostatic agents.

[30]  Yuzhi Zhang,et al.  Distinct endothelial phenotypes evoked by arterial waveforms derived from atherosclerosis-susceptible and -resistant regions of human vasculature. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[31]  A. Cruickshank,et al.  Subarachnoid haemorrhage , 2007, The Lancet.

[32]  M. Daemen,et al.  Cathepsin cysteine proteases in cardiovascular disease , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  V. Nizet,et al.  Interdependence of hypoxic and innate immune responses , 2009, Nature Reviews Immunology.

[34]  K. Nozaki,et al.  Role of TIMP-1 and TIMP-2 in the Progression of Cerebral Aneurysms , 2007, Stroke.

[35]  Rickard Sandberg,et al.  Improved precision and accuracy for microarrays using updated probe set definitions , 2007, BMC Bioinformatics.

[36]  M. Nishimura.  Toll-like receptor 4 expression during cerebral aneurysm formation. , 2010, Journal of neurosurgery.

[37]  E. Edelman,et al.  Heparanase Alters Arterial Structure, Mechanics, and Repair Following Endovascular Stenting in Mice , 2009, Circulation research.

[38]  G. Fassina,et al.  FcγRIIIb Allele-Sensitive Release of α-Defensins: Anti-Neutrophil Cytoplasmic Antibody-Induced Release of Chemotaxins 1 , 2003, The Journal of Immunology.

[39]  H. Kuivaniemi,et al.  Binding Sites for ETS Family of Transcription Factors Dominate the Promoter Regions of Differentially Expressed Genes in Abdominal Aortic Aneurysms , 2009, Circulation. Cardiovascular genetics.

[40]  Shu Chien,et al.  Vascular endothelial responses to altered shear stress: Pathologic implications for atherosclerosis , 2009, Annals of medicine.

[41]  H. Stefánsson,et al.  The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm , 2008, Nature Genetics.

[42]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[43]  R. Moots,et al.  Differential role of neutrophil Fcgamma receptor IIIB (CD16) in phagocytosis, bacterial killing, and responses to immune complexes. , 2002, Arthritis and rheumatism.

[44]  N. Jafari,et al.  Genomics of Human Intracranial Aneurysm Wall , 2009, Stroke.

[45]  G. Dusting,et al.  Transcriptome-Wide Characterization of Gene Expression Associated with Unruptured Intracranial Aneurysms , 2009, European Neurology.

[46]  R. Khalil,et al.  Inflammatory cytokines in vascular dysfunction and vascular disease. , 2009, Biochemical pharmacology.

[47]  Robert Gentleman,et al.  Using GOstats to test gene lists for GO term association , 2007, Bioinform..

[48]  P. Tobias,et al.  Flow-Dependent Regulation of Endothelial Toll-Like Receptor 2 Expression Through Inhibition of SP1 Activity , 2004, Circulation research.

[49]  R. Myers,et al.  Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data , 2005, Nucleic acids research.

[50]  Marko Kangasniemi,et al.  Remodeling of Saccular Cerebral Artery Aneurysm Wall Is Associated With Rupture: Histological Analysis of 24 Unruptured and 42 Ruptured Cases , 2004, Stroke.

[51]  Murim Choi,et al.  Susceptibility loci for intracranial aneurysm in European and Japanese populations , 2008, Nature Genetics.

[52]  KensukeEgashira,et al.  Impact of Monocyte Chemoattractant Protein-1 Deficiency on Cerebral Aneurysm Formation , 2009 .

[53]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[54]  M. Aoki,et al.  Regression of Abdominal Aortic Aneurysms by Simultaneous Inhibition of Nuclear Factor &kgr;B and Ets in a Rabbit Model , 2007, Circulation research.

[55]  J. Chung,et al.  Activation of toll‐like receptors 2, 3 or 5 induces matrix metalloproteinase‐1 and ‐9 expression with the involvement of MAPKs and NF‐κB in human epidermal keratinocytes , 2009, Experimental dermatology.

[56]  A. Algra,et al.  Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[57]  C. Bryant,et al.  Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer , 2009, Pharmacological Reviews.

[58]  Christina Gloeckner,et al.  Modern Applied Statistics With S , 2003 .

[59]  K. Nozaki,et al.  Reactive oxygen species modulate growth of cerebral aneurysms: a study using the free radical scavenger edaravone and p47phox−/− mice , 2009, Laboratory Investigation.

[60]  G. Rinkel,et al.  Genetics of Intracranial Aneurysms , 2008, Stroke.

[61]  P. Törönen,et al.  Changes in gene expression in atherosclerotic plaques analyzed using DNA array. , 2002, Atherosclerosis.

[62]  K. Nozaki,et al.  PITAVASTATIN SUPPRESSES FORMATION AND PROGRESSION OF CEREBRAL ANEURYSMS THROUGH INHIBITION OF THE NUCLEAR FACTOR κB PATHWAY , 2009, Neurosurgery.

[63]  M. Piechota,et al.  Gene Expression Profiles in Human Ruptured and Unruptured Intracranial Aneurysms: What Is the Role of Inflammation? , 2010, Stroke.

[64]  R. Vanninen,et al.  Risk of harboring an unruptured intracranial aneurysm. , 1998, Stroke.

[65]  N. Hashimoto,et al.  Toll-like receptor 4 expression during cerebral aneurysm formation. Laboratory investigation. , 2010, Journal of neurosurgery.